Plain-English translation of NCT06296836 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial investigated a common hospital practice: whether patients with type 2 diabetes should continue taking (a standard diabetes medication) during their hospital stay, or pause it temporarily. Doctors often hold this medication during hospitalization due to safety concerns, but the study wanted to understand if continuing it might actually help or harm patients.
Many hospitals routinely pause when patients are admitted, worried about a rare but serious side effect called lactic acidosis. However, stopping the medication might make blood sugar control worse during hospitalization. This study aimed to find out whether continuing the treatment is actually safer and more beneficial than pausing it.
If you enrolled, you would be randomly assigned to either continue your home dose during your hospital stay or pause it temporarily. The study team would then track your blood sugar levels, watch for any acid-related problems, monitor your symptoms, and follow up after discharge to see how you recovered. The trial has been stopped, so it is no longer enrolling new participants.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States
Phase
Post-approval monitoring
Sponsor
University of Illinois at Chicago
Enrollment target
~22 participants
Started
January 2025
Primary completion
April 2026
Age range
18 Years – 110 Years
Last updated on clinicaltrials.gov in June 2026.